Close

Analyst Ratings for Reneo Pharmaceuticals (RPHM) [Buys]

RPHM Rating Summary

RPHM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RPHM
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $6.56 (+285.9%) * Over Last 12-Mos
Rating Score: 1.3 / 10   Percentile Rank: 9%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/3/2023 BofA Securities Jason Zemansky New Coverage Buy
(N/A)
23.00
(N/A)
6.56
(1.70)
-74.09% Details